Please login to the form below

Not currently logged in
Email:
Password:

Toujeo

This page shows the latest Toujeo news and features for those working in and with pharma, biotech and healthcare.

Sanofi warns of difficult few months as diabetes sales slump

Sanofi warns of difficult few months as diabetes sales slump

Sanofi has been trying to protect the franchise with long-acting follow-up Toujeo but while this made gains - up 14% to 197m - it wasn’t able to do more than

Latest news

More from news
Approximately 9 fully matching, plus 25 partially matching documents found.

Latest Intelligence

  • Going the distance Going the distance

    Following hot on the heels of Afrezza has been Toujeo (insulin glargine), the new basal insulin that will be crucial to moving away from Sanofi's dependence on Lantus. ... We are very much encouraging collaboration, so we are working on pairing the

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics